Maxygen (MAXY) Posts Weaker Q3 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts MAXY Hot Sheet
Price: $2.53 --0%
Financial Fact:
Loss from operations: -2.99M
Today's EPS Names:
CMTL, EQBK, BLK, More
Financial Fact:
Loss from operations: -2.99M
Today's EPS Names:
CMTL, EQBK, BLK, More
Join SI Premium – FREE
Maxygen (Nasdaq: MAXY) reported Q3 EPS of ($0.08), versus ($0.02) reported last year. Revenue for the quarter came in at $555 thousand, versus $734 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASML Holdings (ASML) Tops Q3 EPS by 80c; offers guidance
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
